Samsung Biologics Co.,Ltd. 207940.KS Stock
Samsung Biologics Co.,Ltd. Price Chart
Samsung Biologics Co.,Ltd. 207940.KS Financial and Trading Overview
Samsung Biologics Co.,Ltd. stock price | 790000 KRW |
Previous Close | 778000 KRW |
Open | 780000 KRW |
Bid | 776000 KRW x 0 |
Ask | 777000 KRW x 0 |
Day's Range | 772000 - 783000 KRW |
52 Week Range | 740000 - 922000 KRW |
Volume | 96.41K KRW |
Avg. Volume | 57.6K KRW |
Market Cap | 55.16T KRW |
Beta (5Y Monthly) | 0.577739 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1089690 KRW |
207940.KS Valuation Measures
Enterprise Value | 55.28T KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | 2.91 |
Price/Sales (ttm) | 17.178865 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 17.217 |
Enterprise Value/EBITDA | 40.483 |
Trading Information
Samsung Biologics Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.577739 |
52-Week Change | -6.49% |
S&P500 52-Week Change | 20.43% |
52 Week High | 922000 KRW |
52 Week Low | 740000 KRW |
50-Day Moving Average | 788720 KRW |
200-Day Moving Average | 813880 KRW |
207940.KS Share Statistics
Avg. Volume (3 month) | 57.6K KRW |
Avg. Daily Volume (10-Days) | 61.75K KRW |
Shares Outstanding | 71.17M |
Float | 17.63M |
Short Ratio | N/A |
% Held by Insiders | 75.17% |
% Held by Institutions | 14.25% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 24.69% |
Operating Margin (ttm) | 31.11% |
Gross Margin | 48.97% |
EBITDA Margin | 42.53% |
Management Effectiveness
Return on Assets (ttm) | 5.12% |
Return on Equity (ttm) | 11.79% |
Income Statement
Revenue (ttm) | 3.21T KRW |
Revenue Per Share (ttm) | 45224.75 KRW |
Quarterly Revenue Growth (yoy) | 41.00% |
Gross Profit (ttm) | 1.46T KRW |
EBITDA | 1.37T KRW |
Net Income Avi to Common (ttm) | 792.87B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | -3.50% |
Balance Sheet
Total Cash (mrq) | 2.97T KRW |
Total Cash Per Share (mrq) | 41659.3 KRW |
Total Debt (mrq) | 2.45T KRW |
Total Debt/Equity (mrq) | 26.83 KRW |
Current Ratio (mrq) | 1.574 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.06T KRW |
Levered Free Cash Flow (ttm) | -1000980611072 KRW |
Profile of Samsung Biologics Co.,Ltd.
Country | South Korea |
State | N/A |
City | Incheon |
Address | 300, Songdo Bio-daero |
ZIP | 21987 |
Phone | 82 3 2455 3114 |
Website | https://samsungbiologics.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 4296 |
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Q&A For Samsung Biologics Co.,Ltd. Stock
What is a current 207940.KS stock price?
Samsung Biologics Co.,Ltd. 207940.KS stock price today per share is 790000 KRW.
How to purchase Samsung Biologics Co.,Ltd. stock?
You can buy 207940.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Samsung Biologics Co.,Ltd.?
The stock symbol or ticker of Samsung Biologics Co.,Ltd. is 207940.KS.
Which industry does the Samsung Biologics Co.,Ltd. company belong to?
The Samsung Biologics Co.,Ltd. industry is Biotechnology.
How many shares does Samsung Biologics Co.,Ltd. have in circulation?
The max supply of Samsung Biologics Co.,Ltd. shares is 71.17M.
What is Samsung Biologics Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Samsung Biologics Co.,Ltd. PE Ratio is now.
What was Samsung Biologics Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Samsung Biologics Co.,Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Samsung Biologics Co.,Ltd. company belong to?
The Samsung Biologics Co.,Ltd. sector is Healthcare.